These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4959746)

  • 1. The activity in vitro of Rifamycin SV on various mycobacterial strains including tubercle bacilli isolated from patients never treated with Rifamycin SV.
    Tan THIAM HOK ; The KIE SENG ; Tan LIOE SAN ; Yang SHE YEN ; Widodo S
    Paediatr Indones; 1965; 5(1-2):12-4. PubMed ID: 4959746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. II. Antituberculosis activity of INH and SM in vitro after exposure to PAS.
    Maekawa N; Nakanishi ; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Aug; 46(8):293-4. PubMed ID: 4998861
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. I. Incubating temperature and chemotherapeutic effect].
    Maekawa N; Nakanishi M; Kawai M; Ikeda N; Nakai H
    Kekkaku; 1971 Jul; 46(7):235-7. PubMed ID: 5000367
    [No Abstract]   [Full Text] [Related]  

  • 6. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 7. [Resensitization of resistant mycobacterial strains to antitubercular drugs].
    Vercellino E
    G Mal Infett Parassit; 1968 Feb; 20(2):191-3. PubMed ID: 4984621
    [No Abstract]   [Full Text] [Related]  

  • 8. A survey of mycobacterial isolates from the Randwick Chest Hospital, Sydney, in an 18-month period, 1970 to 1971.
    Abbott MR
    Med J Aust; 1973 Jun; 1(23):1144-6. PubMed ID: 4199110
    [No Abstract]   [Full Text] [Related]  

  • 9. Proportion of tubercle bacilli resistant to drugs in an isolate.
    Crone PB; Lee EM
    Am Rev Respir Dis; 1970 Apr; 101(4):29-30. PubMed ID: 4985800
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.
    Pallanza R; Arioli V; Furesz S; Bolzoni G
    Arzneimittelforschung; 1967 May; 17(5):529-34. PubMed ID: 5631580
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of the geographical spread of drug-resistant tubercle bacilli in a city.
    Tinne JE
    J Med Microbiol; 1971 May; 4(2):P3. PubMed ID: 4998858
    [No Abstract]   [Full Text] [Related]  

  • 12. [Primary resistance to INH, PAS and STM. Significance of individual mycobacterial strains for newly diagnosed cases of pulmonary tuberculosis in the middle Bohemia region in 1967 and 1972 (author's transl)].
    Víznerová A
    Cas Lek Cesk; 1974 Nov; 113(46):1419-22. PubMed ID: 4216401
    [No Abstract]   [Full Text] [Related]  

  • 13. Phage typing of strains of "M. tuberculosis" in the Netherlands.
    Engel HW
    Ann Sclavo; 1975; 17(4):578-83. PubMed ID: 820284
    [No Abstract]   [Full Text] [Related]  

  • 14. [Virulence of INH-resistant tubercle bacilli to the human body. I. Infectiousness of INH-resistant tubercle bacilli].
    Murata A
    Kekkaku; 1967 Sep; 42(9):343-8. PubMed ID: 4966768
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. IV. The bactericidal activity of INH in combination with PAS].
    Maekawa N; Nakanishi M; Kawai M; Nakai H; Ikeda N; Iwai K
    Kekkaku; 1972 Jan; 47(1):1-2. PubMed ID: 4622212
    [No Abstract]   [Full Text] [Related]  

  • 16. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effects of antituberculosis chemotherapy in vitro under various conditions inadequate for the growth of tubercle bacilli. 3. Antituberculosis activity of INH in combination with PAS in vitro after exposure to PAS].
    Maekawa N; Nakanishi M; Kawal M; Nakai H; Ikeda N
    Kekkaku; 1971 Dec; 46(12):491-2. PubMed ID: 5004602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonary tuberculosis with resistant bacilli in untreated patients].
    Israel-Asselain R; Chebat J; Baillet A; Malbos J
    Sem Hop; 1965 Oct; 41(40):2227-9. PubMed ID: 4285182
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibiotics, antiseptics and tubercle bacilli.
    McDonald PJ; Murray CJ; McDonald HM
    Med J Aust; 1974 Jul; 2(2):41-5. PubMed ID: 4212945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.